<DOC>
	<DOCNO>NCT02808000</DOCNO>
	<brief_summary>This prospective , cross-over , randomize , control , partly blind study evaluate safety performance noble metal alloy urinary Catheters ( BIP Foley , Bactiguard AB ) latex silicone . The included patient permanently catheterize spinal cord injure patient Spinalis clinic Rehab station Stockholm , Sweden . Primary Outcome Measures : • The primary objective evaluate efficacy long term suprapubic use BIP Foley catheter , compare use standard catheter time period , re-current symptomatic catheter associate urinary tract infection ( CAUTIs ) . Secondary Outcome Measures : • evaluate safety/performance catheter , i.e . antibiotic use , bacteriuria , bacteremia , urosepsis ICU stay . Exploratory Outcome Measures : • assessment level immunological marker urine , urinary bacterial type resistance pattern , catheter comfort , stability coating , bacterial biofilm catheter surface use .</brief_summary>
	<brief_title>BIP Foley Prevention CAUTI Rehab Station</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>Adult patient ( ≥18 year ) Patients permanent suprapubic urethral catheter ( Foley catheter ) latex silicone At least 3 documented CAUTI infection last year Spinal Cord Injured , change catheter Rehab Station every 10 week ( +/ 2 week ) Children ( ˂18 year ) Participating clinical trial ( ) exposure/treatment could affect outcome present study Stones ( calculus ) urinary tract ( patient include stone remove ) Patients antibiotic treatment ( patient include treatment complete ( +10 day expectance ) )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>